NCT04340128View on ClinicalTrials.gov

Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions
Cutaneous Leishmaniasis
Interventions
DRUG

Meglumine antimoniate

Intra-lesional injection once a week, 0.1/cm2

DRUG

Meglumine antimoniate

Intra-lesional injection twice a week, 0.1/cm2

Trial Locations (1)

14166

CRTSDL, Tehran

All Listed Sponsors
collaborator

Mashad University of Medical Sciences

UNKNOWN

collaborator

Kerman University of Medical Sciences

OTHER

lead

Tehran University of Medical Sciences

OTHER

NCT04340128 - Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL) | Biotech Hunter | Biotech Hunter